In a filing, Immunovant Inc revealed its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $0.13 million on Oct 23 ’24. In the deal valued at $29.53 per share,4,361 shares were sold. As a result of this transaction, Levine Mark S. now holds 322,878 shares worth roughly $9.45 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Geffner Michael sold 3,189 shares, generating $94,171 in total proceeds. Upon selling the shares at $29.53, the Chief Medical Officer now owns 134,971 shares.
Before that, Stout Jay S sold 2,740 shares. Immunovant Inc shares valued at $80,912 were divested by the Chief Technology Officer at a price of $29.53 per share. As a result of the transaction, Stout Jay S now holds 142,186 shares, worth roughly $4.16 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who remained covering the stock and in early October has reiterated a ‘”an Outperform”‘ rating for it. Oppenheimer began covering IMVT with “an Outperform” recommendation on March 28, 2024. Goldman started covering the stock on March 13, 2024. It rated IMVT as “a Buy”.
Price Performance Review of IMVT
On Tuesday, Immunovant Inc [NASDAQ:IMVT] saw its stock fall -6.01% to $29.27. Over the last five days, the stock has lost -3.46%. Immunovant Inc shares have fallen nearly -30.52% since the year began. Nevertheless, the stocks have fallen -10.30% over the past one year. While a 52-week high of $45.58 was reached on 01/09/24, a 52-week low of $24.67 was recorded on 06/10/24. SMA at 50 days reached $29.74, while 200 days put it at $30.27.
Levels Of Support And Resistance For IMVT Stock
The 24-hour chart illustrates a support level at 28.41, which if violated will result in even more drops to 27.55. On the upside, there is a resistance level at 30.66. A further resistance level may holdings at 32.04. The Relative Strength Index (RSI) on the 14-day chart is 46.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.08%. Stochastics %K at 54.28% indicates the stock is a holding.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2024-10-31, growing by 0.46 million shares to a total of 13.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 12.64 million shares. There was a rise of 3.49%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 20, 2024 when JP Morgan began covering the stock and recommended ‘”an Overweight”‘ rating along with a $51 price target.
